nference and BeiGene Collaborate to Drive New B-Cell Cancer Research

nference | Forty percent of people with coronavirus infections have no symptoms. Might they be the key to ending the pandemic?

Unlock actionable insights to improve patient outcomes and optimize healthcare delivery with data-driven solutions.

For Health Systems

With our partners - industry leaders, innovators and leading institutions - we’re delivering real-world data insights and shaping transformative solutions in healthcare.  

Harness diverse real-world data types to gain insights across genomic, clinical, and operational dimensions

Data Modality

Deeply integrated gene panel and whole exome sequencing data powered with Agentic AI Solutions

Patient-Consented Biobank

nference’s platform and tools transform real world data into actionable insights for healthcare innovation.

Streamline research with AI-powered tools that transform complex data into actionable medical insights

For Clinical Researchers

Access advanced datasets and cutting-edge analytics to power innovation in healthcare and life sciences.

For Data Scientists

nSights turns complex healthcare data into actionable insights, driving innovation and smarter decision-making in medical research and development.

Revolutionize drug development through AI-driven insights, accelerating timelines and improving clinical trial outcomes.

For Bio Pharma

Empower device innovation with robust data integration and advanced analytics for regulatory and market success.

Medical Devices

Our AI-driven solutions empower clinical trial design, enhance innovation in product development and streamline regulatory submissions.

Characterization of Patients With Narcolepsy Treated vs Not Treated With Sodium Oxybate: A Propensity Score–Matched Cohort Study

Associations of the Fibrosis-4 Index With Rates of Cardiac Events and Liver Decompensation, and the Potential Implications on Risk Stratification in Patients With Nonalcoholic Steatohepatitis.

Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence

{
"Electrocardiograms": "",
"Gastro-intestinal": "",
"Cardiology": "",
"Metabolic Diseases": "",
"Real-world Effectiveness": "",
"Epidemiology": "",
"Covid-19": "",
"Oncology": "",
"Hepatology": "",
"Mesothelioma": "",
"NSCLC": "",
}

nference's extensive library of publications showcase cutting-edge research and healthcare advancements.

Blogs

nference Establishes AI Initiative with Takeda to Advance Precision Medicine in Inflammatory Bowel Disease

News

Our latest blogs and insights cover industry trends, technological breakthroughs, and expert insights, to keep you updated on the forefront of healthcare innovation.

Cutting-edge AI solutions to transform cardiac care

Empowering digital pathology with a new WSI paradigm

Navbar v2

New research suggests that some of us may be partially protected due to past encounters with common cold coronaviruses.

Forty percent of people with coronavirus infections have no symptoms. Might they be the key to ending the pandemic?